Evidence map›Paper›PMID 28859227›Full record

ArticleHepatology (Baltimore, Md.)2018

Transmembrane BAX Inhibitor motif-containing 1, a novel anti-inflammatory approach for nonalcoholic steatohepatitis treatment.

Alexander Wree, Maria Eugenia Inzaugarat, Ariel E Feldstein

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Hepatology (Baltimore, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Foods (Basel, Switzerland) · 2019
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Alexander WreeDepartment of Internal Medicine III, University Hospital RWTH-Aachen, Aachen, Germany.
Maria Eugenia InzaugaratDepartment of Internal Medicine III, University Hospital RWTH-Aachen, Aachen, Germany.
Ariel E FeldsteinDepartment of Pediatric Gastroenterology, University of California San Diego (UCSD), and Rady Children's Hospital, San Diego, CA.

Funding

Sterile inflammation and pyroptotic cell death in liver fibrosisR01DK113592 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ariel Feldstein, HAROLD M HOFFMAN · 2017 to 2026
$4.8M
Oxidized Metabolites of Linoleic Acid in Alcohol-induced Liver InjuryU01AA022489 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDSTEIN, ARIEL, MCCLAIN, CRAIG J. · 2014 to 2018
$1.7M
Caspase Dependent Cell Death in Nonalcoholic Fatty Liver DiseaseR01DK082451 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDSTEIN, ARIEL · 2009 to 2012
$1.4M
Gain of function mutations in inflammasome related genes in human and experimental alcoholic liver diseaseU01AA024206 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDSTEIN, ARIEL · 2017 to 2018
$671k
NIAAA NIH HHS U01 AA022489NIAAA NIH HHS U01 AA024206NIDDK NIH HHS R01 DK082451NIDDK NIH HHS R01 DK113592
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Liver CirrhosisNon-alcoholic Fatty Liver DiseaseAnti-Inflammatory AgentsHumansAnti-Inflammatory Agents

Identifiers

PMID28859227
PMCPMC5770148

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.